한글목차

세계 보조생식술(ART) 시장은 2018년 286억 2,400만 달러로 평가되었으며, 2023년까지 연평균 5.0% 이상 성장할 것으로 예상됩니다.

PCOS의 유병률 증가

다낭성 난소증후군(PCOS)의 높은 유병률이 실적 기간 동안 보조생식술(ART) 시장의 성장을 뒷받침한 것으로 나타났습니다. 난소를 가진 가임기 여성에게 가장 흔한 내분비(호르몬) 질환으로, 전체 인구의 5-10%가 앓고 있으며, 인공수정은 PCOS 환자에게 맞춤화된 치료 옵션을 제공하여 PCOS와 관련된 생식 관련 문제를 해결하고 임신 및 임신 성공 가능성을 높입니다. 체외수정은 난소에서 난자를 채취하여 실험실에서 정자와 수정시킨 후 배아를 자궁에 이식하는 고급 ART 치료법으로, PCOS는 여성 불임의 주요 원인 중 하나이며 "무배란성"(배란이 없는) 불임의 80%를 차지하는 것으로 추산됩니다. 체외수정은 PCOS 여성의 임신 가능성을 높이기 위한 가장 일반적인 치료법 중 하나입니다. 또한, 스위스의 전문 기관인 WHO에 따르면 전 세계적으로 약 1억 1,600만 명(3.4%)의 여성이 PCOS를 앓고 있는 것으로 추정하고 있습니다. 따라서, PCOS 사례 증가는 지난 기간 동안 보조생식술(ART) 시장의 성장을 주도했습니다.

목차

제1장 주요 요약

• 보조생식기술(ART) - 시장의 매력과 거시경제 상황

제2장 목차

제3장 표 리스트

제4장 그래프 리스트

제5장 보고서의 구성

제6장 시장 특징

• 일반적인 시장의 정의
• 개요
• 보조생식기술(ART) 시장 정의와 세분화
• 시장 세분화 : 기술별
  • 체외수정(IVF)
  • 인공수정(AI-IUI)
  • 기타 기술
• 시장 세분화 : 시술 유형별
  • 신선 비기증자
  • 신규 기증자
  • 동결 기증자
  • 동결 비기증자
  • 배아 또는 난자 은행
• 시장 세분화 : 최종사용자별
  • 병원
  • 불임 치료 클리닉
  • 기타 최종사용자
• 시장 세분화 진단 : 검사별
  • 배란 검사
  • 자궁 난관 조영술
  • 난소 예비 검사
  • 유전자 검사
  • 기타 검사

제7장 주요 시장 동향

제8장 보조생식기술(ART) 시장 : 거시경제 시나리오

• COVID-19의 영향 : 보조생식기술(ART) 시장
• 우크라이나 전쟁의 영향 : 보조생식기술(ART) 시장
• 고인플레이션의 영향 : 보조생식기술(ART) 시장

제9장 세계 시장 규모와 성장

• 시장 규모
• 시장 성장 실적, 2018-2023
  • 시장 성장 촉진요인, 2018-2023년
  • 시장 성장 억제요인, 2018-2023년
• 시장 성장 예측, 2023-2028년, 2033년
  • 시장 성장 촉진요인, 2023-2028년
  • 시장 성장 억제요인, 2023-2028년

제10장 세계의 보조생식기술(ART) 시장 : 세분화

• 세계의 보조생식기술(ART) 시장 : 기술별, 분석과 예측, 2018-2023년, 2028년, 2033년
• 세계의 보조생식기술(ART) 시장 : 시술 유형별, 분석과 예측, 2018-2023년, 2028년, 2033년
• 세계의 보조생식기술(ART) 시장 : 최종사용자별, 분석과 예측, 2018-2023년, 2028년, 2033년
• 보조생식기술(ART) 검사 시장(ART 검사/진단), 분석과 예측, 2018-2023년, 2028년, 2033년
  • 세계의 기타 검사 시장 : ART 검사/진단별, 분석과 예측, 2018-2023년, 2028년, 2033년

제11장 보조생식기술(ART) 시장 : 지역 및 국가별 분석

• 세계의 보조생식기술(ART) 시장 : 지역별, 분석과 예측, 2018-2023년, 2028년, 2033년
• 세계의 보조생식기술(ART) 시장 : 국가별, 분석과 예측, 2018-2023년, 2028년, 2033년

제12장 아시아태평양 시장

제13장 서유럽 시장

제14장 동유럽 시장

제15장 북미 시장

제16장 남미 시장

제17장 중동 시장

제18장 아프리카 시장

제19장 경쟁 구도와 기업 개요

• Vitrolife AB
• Ferring B.V.
• Progyny Inc.
• CooperSurgical Inc.
• FUJIFILM Irvine Scientific, Inc.

제20장 경쟁 벤치마킹

제21장 경쟁 대시보드

제22장 주요 인수합병(M&A)

• Hamilton Thorne Acquired Gynetics Medical Products
• Reproductive Medicine Associates(RMA) And IVI-RMA Acquired Conceptions Reproductive Associates of Colorado
• BPEA EQT Acquired Indira IVF
• Calibre Scientific Acquired Microm UK Limited And Scopescreen
• Liverpool Partners Acquired Genea Ltd.

제23장 기회와 전략

• 세계의 보조생식기술(ART) 시장(2028년) : 새로운 기회를 제공하는 국가
• 세계의 보조생식기술(ART) 시장(2028년) : 새로운 기회를 제공하는 부문
• 세계의 보조생식기술(ART) 시장(2028년) : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제24장 보조생식기술(ART) 시장 : 결론과 제안

• 결론
• 제안
  • 제품
  • 장소
  • 가격
  • 프로모션
  • 사람들

제25장 부록

영문목차

Assisted reproductive technology (ART) refers to fertility treatments and procedures that involve the manipulation of eggs, sperm or embryos to increase the likelihood of a successful pregnancy in humans. ART includes all fertility treatments in which either the eggs or the embryos are handled.

The assisted reproductive technology (ART) market consists of sales, by entities (organizations, sole traders and partnerships), of assisted reproductive technology (ART) procedures that are used for the treatment of infertility.

The global assisted reproductive technology (ART) market was valued at $28,624.0 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 5.0%.

Increasing Prevalence Of PCOS

The high prevalence of PCOS (polycystic ovary syndrome) condition supported the assisted reproductive technology market growth in the historic period. PCOS is a hormonal disorder that occurs in women of reproductive age. It is the most common endocrine (hormone) disorder in reproductive-age people with ovaries, affecting, conservatively, 5-10% of that population. ART offers tailored treatment options for individuals with PCOS, addressing the specific reproductive challenges associated with the condition and increasing the likelihood of successful conception and pregnancy. IVF is a more advanced ART procedure that involves the retrieval of eggs from the ovaries, fertilization with sperm in a laboratory setting, and transferring resulting embryos into the uterus. PCOS is one of the leading causes of female infertility, responsible for an estimated 80% of "anovulatory" (no ovulation) infertility cases. IVF is one of the most common treatments for women to increase fertility in women with PCOS. Furthermore, according to WHO, a Switzerland-based specialized agency, approximately 116 million women (3.4%) are affected by PCOS globally. Therefore, increased cases of PCOS drove the assisted reproductive technology market growth in the historic period.

Impact Of Artificial Intelligence On Assisted Reproductive Technology

Several key players operating in the assisted reproductive technology market are integrating efforts to introduce technological innovations, such as artificial intelligence (AI) software, to advance IVF treatment outcomes and lower the costs of the treatment. In IVF, AI algorithms analyze vast amounts of data from patient medical records, lab tests and imaging studies to identify patterns and make predictions. For instance, in October 2022, Alife, a US-based AI-based health technology firm, launched new artificial intelligence software to help fertility clinics optimize and support clinical decision-making during critical stages of the IVF process. Alife uses AI and significant U.S. IVF data sets to examine millions of patient cycle data points. The company's technology can help optimize the IVF treatment process from start to finish by reducing clinic operations and giving patients a more tailored experience.

The global assisted reproductive technology market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 17.9% of the total market in 2022.

Assisted Reproductive Technology Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global assisted reproductive technology market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for assisted reproductive technology? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The assisted reproductive technology market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider assisted reproductive technology market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by technology, by diagnosis/testing, by procedure type and by end-user.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the assisted reproductive technology market.
• Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by technology, by diagnosis/testing, by procedure type and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for assisted reproductive technology providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Technology: In Vitro-Fertilization (IVF); Artificial Insemination (AI-IUI); Other Technologies
• 2) By Procedure Type: Fresh Non-Donor; Fresh Donor; Frozen Donor; Frozen Non-Donor; Embryo or Egg Banking
• 3) By End-User: Hospitals; Fertility Clinics; Other End-Users
• 4) By Testing/Diagnosis: In Ovulation Testing; Hysterosalpingography; Ovarian Reserve Testing; Genetic Testing; Other Tests
• Companies Mentioned: Vitrolife; Ferring B.V.; Progyny Inc.; CooperSurgical Inc.; FUJIFILM Irvine Scientific, Inc.
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; assisted reproductive technology indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Assisted Reproductive Technology - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Assisted Reproductive Technology Market Definition And Segmentations
• 6.4 Market Segmentation By Technology
  • 6.4.1 In Vitro-Fertilization (IVF)
  • 6.4.2 Artificial Insemination (AI-IUI)
  • 6.4.3 Other Technologies
• 6.5 Market Segmentation By Procedure Type
  • 6.5.1 Fresh Non-Donor
  • 6.5.2 Fresh Donor
  • 6.5.3 Frozen Donor
  • 6.5.4 Frozen Non-Donor
  • 6.5.5 Embryo Or Egg Banking
• 6.6 Market Segmentation By End-User
  • 6.6.1 Hospitals
  • 6.6.2 Fertility Clinics
  • 6.6.3 Other End-Users
• 6.7 Market Segmentation By Diagnosis/Testing
  • 6.7.1 Ovulation Testing
  • 6.7.2 Hysterosalpingography
  • 6.7.3 Ovarian Reserve Testing
  • 6.7.4 Genetic Testing
  • 6.7.5 Other Test
    • 6.7.5.1 Computer Assisted Semen Analysis
    • 6.7.5.2 Sperm Penetration Assay
    • 6.7.5.3 Microscopic Examination
    • 6.7.5.4 Others Testing/Diagnosis

7 Major Market Trends

• 7.1 Key Players Launching Innovative Programs To Promote ART and Support Sustainability
• 7.2 Impact Of Artificial Intelligence On Assisted Reproductive Technology
• 7.3 Advanced Technological Solutions In Assisted Reproductive Technology
• 7.4 Blockchain Integration In Assisted Reproductive Technology
• 7.5 Strategic Collaborations Driving Innovation In Assisted Reproductive Technology
• 7.6 Innovative Fertility Treatment Options To Enhance Access To Care

8 Assisted Reproductive Technology Market - Macro Economic Scenario

• 8.1 COVID-19 Impact On The Assisted Reproductive Technology Market
• 8.2 Impact Of The War In Ukraine On The Assisted Reproductive Technology Market
• 8.3 Impact Of High Inflation On The Assisted Reproductive Technology Market

9 Global Market Size and Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
  • 9.2.1 Market Drivers 2018 - 2023
  • 9.2.2 Market Restraints 2018 - 2023
• 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
  • 9.3.1 Market Drivers 2023 - 2028
  • 9.3.2 Market Restraints 2023 - 2028

10 Global Assisted Reproductive Technology Market Segmentation

• 10.1 Global Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.2 Global Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.3 Global Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.4 Global Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4.1 Global Other Tests Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Assisted Reproductive Technology Market, Regional and Country Analysis

• 11.1 Global Assisted Reproductive Technology Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.2 Global Assisted Reproductive Technology Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

• 12.1 Summary
  • 12.1.1 Market Overview
  • 12.1.2 Region Information
  • 12.1.3 Market Information
  • 12.1.4 Background Information
  • 12.1.5 Government Initiatives
  • 12.1.6 Regulations
  • 12.1.7 Regulatory Bodies
  • 12.1.8 Major Associations
  • 12.1.9 Taxes Levied
  • 12.1.10 Corporate Tax Structure
  • 12.1.11 Investments
  • 12.1.12 Major Companies
• 12.2 Asia-Pacific Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.3 Asia-Pacific Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.4 Asia-Pacific Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.5 Asia-Pacific Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.6 Asia-Pacific Assisted Reproductive Technology Market: Country Analysis
• 12.7 China Market
• 12.8 Summary
  • 12.8.1 Market Overview
  • 12.8.2 Country Information
  • 12.8.3 Market Information
  • 12.8.4 Background Information
  • 12.8.5 Government Initiatives
  • 12.8.6 Regulations
  • 12.8.7 Regulatory Bodies
  • 12.8.8 Major Associations
  • 12.8.9 Taxes Levied
  • 12.8.10 Corporate Tax Structure
  • 12.8.11 Investments
  • 12.8.12 Major Companies
• 12.9 China Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.10 China Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.11 China Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.12 China Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.13 India Market
• 12.14 India Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.15 India Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.16 India Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.17 India Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.18 Japan Market
• 12.19 Japan Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.20 Japan Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.21 Japan Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.22 Japan Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.23 Australia Market
• 12.24 Australia Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.25 Australia Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.26 Australia Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.27 Australia Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.28 Indonesia Market
• 12.29 Indonesia Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.30 Indonesia Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.31 Indonesia Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.32 Indonesia Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.33 South Korea Market
• 12.34 South Korea Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.35 South Korea Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.36 South Korea Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.37 South Korea Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

• 13.1 Summary
  • 13.1.1 Market Overview
  • 13.1.2 Region Information
  • 13.1.3 Market Information
  • 13.1.4 Background Information
  • 13.1.5 Government Initiatives
  • 13.1.6 Regulations
  • 13.1.7 Regulatory Bodies
  • 13.1.8 Major Associations
  • 13.1.9 Taxes Levied
  • 13.1.10 Corporate Tax Structure
  • 13.1.11 Investments
  • 13.1.12 Major Companies
• 13.2 Western Europe Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.3 Western Europe Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.4 Western Europe Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.5 Western Europe Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.6 Western Europe Assisted Reproductive Technology Market: Country Analysis
• 13.7 UK Market
• 13.8 UK Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.9 UK Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.10 UK Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.11 UK Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.12 Germany Market
• 13.13 Germany Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.14 Germany Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.15 Germany Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.16 Germany Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.17 France Market
• 13.18 France Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.19 France Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.20 France Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.21 France Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.22 Italy Market
• 13.23 Italy Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.24 Italy Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.25 Italy Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.26 Italy Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.27 Spain Market
• 13.28 Spain Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.29 Spain Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.30 Spain Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.31 Spain Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

• 14.1 Summary
  • 14.1.1 Market Overview
  • 14.1.2 Region Information
  • 14.1.3 Market Information
  • 14.1.4 Background Information
  • 14.1.5 Government Initiatives
  • 14.1.6 Regulations
  • 14.1.7 Regulatory Bodies
  • 14.1.8 Major Associations
  • 14.1.9 Taxes Levied
  • 14.1.10 Corporate Tax Structure
  • 14.1.11 Investments
  • 14.1.12 Major Companies
• 14.2 Eastern Europe Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.3 Eastern Europe Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.4 Eastern Europe Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.5 Eastern Europe Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.6 Eastern Europe Assisted Reproductive Technology Market: Country Analysis
• 14.7 Russia Market
• 14.8 Russia Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.9 Russia Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.10 Russia Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.11 Russia Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

• 15.1 Summary
  • 15.1.1 Market Overview
  • 15.1.2 Region Information
  • 15.1.3 Market Information
  • 15.1.4 Background Information
  • 15.1.5 Government Initiatives
  • 15.1.6 Regulations
  • 15.1.7 Regulatory Bodies
  • 15.1.8 Major Associations
  • 15.1.9 Taxes Levied
  • 15.1.10 Corporate Tax Structure
  • 15.1.11 Investments
  • 15.1.12 Major Companies
• 15.2 North America Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.3 North America Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.4 North America Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.5 North America Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.6 North America Assisted Reproductive Technology Market: Country Analysis
• 15.7 USA Market
• 15.8 Summary
  • 15.8.1 Market Overview
  • 15.8.2 Country Information
  • 15.8.3 Market Information
  • 15.8.4 Background Information
  • 15.8.5 Government Initiatives
  • 15.8.6 Regulations
  • 15.8.7 Regulatory Bodies
  • 15.8.8 Major Associations
  • 15.8.9 Taxes Levied
  • 15.8.10 Corporate Tax Structure
  • 15.8.11 Investments
  • 15.8.12 Major Companies
• 15.9 USA Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.10 USA Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.11 USA Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.12 USA Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.13 Canada Market
• 15.14 Canada Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.15 Canada Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.16 Canada Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.17 Canada Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

• 16.1 Summary
  • 16.1.1 Market Overview
  • 16.1.2 Region Information
  • 16.1.3 Market Information
  • 16.1.4 Background Information
  • 16.1.5 Government Initiatives
  • 16.1.6 Regulations
  • 16.1.7 Regulatory Bodies
  • 16.1.8 Major Associations
  • 16.1.9 Taxes Levied
  • 16.1.10 Corporate Tax Structure
  • 16.1.11 Investments
  • 16.1.12 Major Companies
• 16.2 South America Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.3 South America Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.4 South America Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.5 South America Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.6 South America Assisted Reproductive Technology Market: Country Analysis
• 16.7 Brazil Market
• 16.8 Brazil Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.9 Brazil Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.10 Brazil Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.11 Brazil Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

• 17.1 Summary
  • 17.1.1 Market Overview
  • 17.1.2 Region Information
  • 17.1.3 Market Information
  • 17.1.4 Background Information
  • 17.1.5 Government Initiatives
  • 17.1.6 Regulations
  • 17.1.7 Regulatory Bodies
  • 17.1.8 Major Associations
  • 17.1.9 Taxes Levied
  • 17.1.10 Corporate Tax Structure
  • 17.1.11 Investments
  • 17.1.12 Major Companies
• 17.2 Middle East Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.3 Middle East Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.4 Middle East Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.5 Middle East Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

• 18.1 Summary
  • 18.1.1 Market Overview
  • 18.1.2 Region Information
  • 18.1.3 Market Information
  • 18.1.4 Background Information
  • 18.1.5 Government Initiatives
  • 18.1.6 Regulations
  • 18.1.7 Regulatory Bodies
  • 18.1.8 Major Associations
  • 18.1.9 Taxes Levied
  • 18.1.10 Corporate Tax Structure
  • 18.1.11 Investments
  • 18.1.12 Major Companies
• 18.2 Africa Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.3 Africa Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.4 Africa Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.5 Africa Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

• 19.1 Vitrolife AB
  • 19.1.1 Company Overview
  • 19.1.2 Products And Services
  • 19.1.3 Business Strategy
  • 19.1.4 Financial performance
• 19.2 Ferring B.V.
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Business Strategy
  • 19.2.4 Financial performance
• 19.3 Progyny Inc.
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Business Strategy
  • 19.3.4 Financial Performance
• 19.4 CooperSurgical Inc.
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Business Strategy
  • 19.4.4 Financial Overview
• 19.5 FUJIFILM Irvine Scientific, Inc.
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Business Strategy
  • 19.5.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

• 22.1 Hamilton Thorne Acquired Gynetics Medical Products
• 22.2 Reproductive Medicine Associates (RMA) And IVI-RMA Acquired Conceptions Reproductive Associates of Colorado
• 22.3 BPEA EQT Acquired Indira IVF
• 22.4 Calibre Scientific Acquired Microm UK Limited And Scopescreen
• 22.5 Liverpool Partners Acquired Genea Ltd.

23 Opportunities And Strategies

• 23.1 Global Assisted Reproductive Technology Market In 2028 - Countries Offering Most New Opportunities
• 23.2 Global Assisted Reproductive Technology Market In 2028 - Segments Offering Most New Opportunities
• 23.3 Global Assisted Reproductive Technology Market In 2028 - Growth Strategies
  • 23.3.1 Market Trend Based Strategies
  • 23.3.2 Competitor Strategies

24 Assisted Reproductive Technology Market, Conclusions And Recommendations

• 24.1 Conclusions
• 24.2 Recommendations
  • 24.2.1 Product
  • 24.2.2 Place
  • 24.2.3 Price
  • 24.2.4 Promotion
  • 24.2.5 People

25 Appendix

• 25.1 Geographies Covered
• 25.2 Market Data Sources
• 25.3 Research Methodology
• 25.4 Currencies
• 25.5 The Business Research Company
• 25.6 Copyright and Disclaimer